Atria Investments increased its position in HCP, Inc. (NYSE:HCP) by 14.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,991 shares of the real estate investment trust’s stock after buying an additional 2,828 shares during the period. Atria Investments’ holdings in HCP were worth $837,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. LGT Capital Partners boosted its stake in HCP by 12.5% in the fourth quarter. LGT Capital Partners now owns 350,090 shares of the real estate investment trust’s stock worth $13,387,000 after buying an additional 39,020 shares in the last quarter. Nisa Investment Advisors boosted its stake in HCP by 2.3% in the fourth quarter. Nisa Investment Advisors now owns 134,446 shares of the real estate investment trust’s stock worth $5,141,000 after buying an additional 2,960 shares in the last quarter. Curbstone Financial Management boosted its stake in HCP by 71.7% in the fourth quarter. Curbstone Financial Management now owns 53,650 shares of the real estate investment trust’s stock worth $2,052,000 after buying an additional 22,400 shares in the last quarter. Raymond James Trust boosted its stake in HCP by 23.5% in the fourth quarter. Raymond James Trust now owns 33,961 shares of the real estate investment trust’s stock worth $1,299,000 after buying an additional 6,455 shares in the last quarter. Finally, Creative Planning boosted its stake in HCP by 24.1% in the fourth quarter. Creative Planning now owns 25,502 shares of the real estate investment trust’s stock worth $975,000 after buying an additional 4,957 shares in the last quarter.

Shares of HCP, Inc. (NYSE:HCP) opened at 35.94 on Friday. The company’s 50 day moving average price is $36.83 and its 200-day moving average price is $37.23. HCP, Inc. has a 52 week low of $32.71 and a 52 week high of $47.30. The company has a market capitalization of $16.71 billion and a price-to-earnings ratio of 72.02.

HCP (NYSE:HCP) last posted its quarterly earnings results on Tuesday, November 3rd. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. The company earned $657.95 million during the quarter, compared to analysts’ expectations of $599.42 million. HCP’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter last year, the company earned $0.75 earnings per share. Analysts anticipate that HCP, Inc. will post $3.14 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, February 23rd. Shareholders of record on Monday, February 8th will be paid a dividend of $0.575 per share. This represents a $2.30 dividend on an annualized basis and a yield of 6.40%. The ex-dividend date of this dividend is Thursday, February 4th. This is an increase from HCP’s previous quarterly dividend of $0.57.

HCP has been the topic of a number of recent research reports. Mizuho lowered their target price on HCP from $41.00 to $37.00 in a report on Monday, October 26th. Cowen and Company decreased their price objective on HCP from $40.00 to $39.00 and set a “market perform” rating on the stock in a research note on Thursday, December 17th. Zacks Investment Research downgraded HCP from a “buy” rating to a “hold” rating in a research note on Monday, October 12th. BMO Capital Markets decreased their price objective on HCP from $38.50 to $36.00 in a research note on Wednesday, November 4th. Finally, Jefferies Group downgraded HCP from a “hold” rating to an “underperform” rating and decreased their price objective for the stock from $39.00 to $30.00 in a research note on Tuesday, January 12th. Seven analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $38.30.

In other HCP news, EVP Kendall K. Young purchased 2,900 shares of the business’s stock in a transaction on Friday, November 6th. The shares were bought at an average cost of $33.95 per share, for a total transaction of $98,455.00. Following the completion of the purchase, the executive vice president now directly owns 34,449 shares in the company, valued at $1,169,543.55. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Peter L. Rhein sold 5,600 shares of the firm’s stock in a transaction on Tuesday, December 8th. The shares were sold at an average price of $36.43, for a total value of $204,008.00. The disclosure for this sale can be found here.

HCP, Inc. (NYSE:HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.

12 Month Chart for NYSE:HCP

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.